Use of an H+, K+-atpase inhibitor in the treatment of nasal polyps
First Claim
Patent Images
1. A method for the treatment of nasal polyps which comprises administering a pharmaceutical formulation comprising an H+, K+-ATPase inhibitor to a subject in need of such treatment.
3 Assignments
0 Petitions
Accused Products
Abstract
The invention provides a method for the treatment of polyposis which comprises treating a subject suffering from polyposis with an H+,K+-ATPase inhibitor and, optionally, a glucocorticoid. The invention also relates to a pharmaceutical formulation for simultaneous, separate or sequential administration in the treatment of Widal'"'"'s Syndrome and in the treatment of asthma.
-
Citations
8 Claims
- 1. A method for the treatment of nasal polyps which comprises administering a pharmaceutical formulation comprising an H+, K+-ATPase inhibitor to a subject in need of such treatment.
- 2. A method for the treatment of nasal polyps which comprises administering simultaneously, separately or sequentially a pharmaceutical formulation comprising an H+,K+-ATPase inhibitor and a glucocorticoid to a subject in need of such treatment.
Specification